75 related articles for article (PubMed ID: 17402598)
1. [The role of changes in the functional activity and the amount of p-glycoprotein in drug pharmacokinetics].
Ramenskaia GV; Faĭnshteĭn SL; Sychev DA
Eksp Klin Farmakol; 2007; 70(1):72-80. PubMed ID: 17402598
[TBL] [Abstract][Full Text] [Related]
2. Role of P-glycoprotein in pharmacokinetics: clinical implications.
Lin JH; Yamazaki M
Clin Pharmacokinet; 2003; 42(1):59-98. PubMed ID: 12489979
[TBL] [Abstract][Full Text] [Related]
3. Multidrug resistance P-glycoprotein: crucial significance in drug disposition and interaction.
Sun J; He ZG; Cheng G; Wang SJ; Hao XH; Zou MJ
Med Sci Monit; 2004 Jan; 10(1):RA5-14. PubMed ID: 14704647
[TBL] [Abstract][Full Text] [Related]
4. Does inhibition of P-glycoprotein lead to drug-drug interactions?
Balayssac D; Authier N; Cayre A; Coudore F
Toxicol Lett; 2005 Apr; 156(3):319-29. PubMed ID: 15763631
[TBL] [Abstract][Full Text] [Related]
5. Interactions between P-glycoprotein substrates and other cationic drugs at the hepatic excretory level.
Smit JW; Duin E; Steen H; Oosting R; Roggeveld J; Meijer DK
Br J Pharmacol; 1998 Feb; 123(3):361-70. PubMed ID: 9504375
[TBL] [Abstract][Full Text] [Related]
6. Circadian variations in exsorptive transport: in situ intestinal perfusion data and in vivo relevance.
Okyar A; Dressler C; Hanafy A; Baktir G; Lemmer B; Spahn-Langguth H
Chronobiol Int; 2012 May; 29(4):443-53. PubMed ID: 22489638
[TBL] [Abstract][Full Text] [Related]
7. [P-glycoprotein: structure, physiological role and molecular mechanisms of modulation functional activity].
Iakusheva EN; Chernykh IV; Shchul'kin AV; Popova NM
Usp Fiziol Nauk; 2014; 45(4):89-98. PubMed ID: 25729846
[TBL] [Abstract][Full Text] [Related]
8. The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter.
Romsicki Y; Sharom FJ
Biochemistry; 1999 May; 38(21):6887-96. PubMed ID: 10346910
[TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein: from genomics to mechanism.
Ambudkar SV; Kimchi-Sarfaty C; Sauna ZE; Gottesman MM
Oncogene; 2003 Oct; 22(47):7468-85. PubMed ID: 14576852
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of the human MDR1 drug transporter.
Schwab M; Eichelbaum M; Fromm MF
Annu Rev Pharmacol Toxicol; 2003; 43():285-307. PubMed ID: 12359865
[TBL] [Abstract][Full Text] [Related]
11. Characterization of binding properties to human P-glycoprotein: development of a [3H]verapamil radioligand-binding assay.
Döppenschmitt S; Langguth P; Regårdh CG; Andersson TB; Hilgendorf C; Spahn-Langguth H
J Pharmacol Exp Ther; 1999 Jan; 288(1):348-57. PubMed ID: 9862789
[TBL] [Abstract][Full Text] [Related]
12. Drug transport by reconstituted P-glycoprotein in proteoliposomes. Effect of substrates and modulators, and dependence on bilayer phase state.
Lu P; Liu R; Sharom FJ
Eur J Biochem; 2001 Mar; 268(6):1687-97. PubMed ID: 11248688
[TBL] [Abstract][Full Text] [Related]
13. Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport.
Varma MV; Sateesh K; Panchagnula R
Mol Pharm; 2005; 2(1):12-21. PubMed ID: 15804173
[TBL] [Abstract][Full Text] [Related]
14. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
Kamath AV; Wang J; Lee FY; Marathe PH
Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
[TBL] [Abstract][Full Text] [Related]
15. Pregnane X receptor (PXR) regulates P-glycoprotein at the blood-brain barrier: functional similarities between pig and human PXR.
Ott M; Fricker G; Bauer B
J Pharmacol Exp Ther; 2009 Apr; 329(1):141-9. PubMed ID: 19147857
[TBL] [Abstract][Full Text] [Related]
16. P-Glycoprotein- and cytochrome P-450-mediated herbal drug interactions.
Kumar YS; Adukondalu D; Sathish D; Vishnu YV; Ramesh G; Latha AB; Reddy PC; Sarangapani M; Rao YM
Drug Metabol Drug Interact; 2010; 25(1-4):3-16. PubMed ID: 21417789
[TBL] [Abstract][Full Text] [Related]
17. How does P-glycoprotein recognize its substrates?
Ueda K; Taguchi Y; Morishima M
Semin Cancer Biol; 1997 Jun; 8(3):151-9. PubMed ID: 9441945
[TBL] [Abstract][Full Text] [Related]
18. Multiple recognition of various amphiphilic molecules by the multidrug resistance P-glycoprotein: molecular mechanisms and pharmacological consequences coming from functional interactions between various drugs.
Orlowski S; Garrigos M
Anticancer Res; 1999; 19(4B):3109-23. PubMed ID: 10652600
[TBL] [Abstract][Full Text] [Related]
19. Importance of P-glycoprotein at blood-tissue barriers.
Fromm MF
Trends Pharmacol Sci; 2004 Aug; 25(8):423-9. PubMed ID: 15276711
[TBL] [Abstract][Full Text] [Related]
20. The kidney--the body's playground for drugs: an overview of renal drug handling with selected clinical correlates.
Perri D; Ito S; Rowsell V; Shear NH
Can J Clin Pharmacol; 2003; 10(1):17-23. PubMed ID: 12687033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
